Intended to aid in the rapid diagnosis of SARS-CoV-2 infections, the Orient Gene Covid-19 Antigen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider.
Rapid chromatographic immunoassay (lateral-flow) for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days from the onset of symptoms.
The IgA / IgM / IgG Antibody Combined Rapid Test can be used to evaluate the course of disease.
T1 indicates the detection results of IgA and (or) IgM, and the detection significance is to assist the diagnosis of early and present infection. T2 is the result of IgG detection, and the significance of detection is to assist the diagnosis of mid-term or previous infection.
Intended to aid in the rapid diagnosis of SARS-CoV-2 infections, the Healgen Covid-19 Antigen Test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider.
A rapid test for the detection of SARS-CoV-2 antigens in anterior nasal specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection.
